Effects of anti‑VEGF on peripapillary retinal nerve fiber layer and papillary/peripapillary blood circulation in retinopathies (Review)
- Authors:
- Hongwei Wang
- Renfeng Ding
- Wenya Jiang
- Siyi Li
- Yijuan Wu
- Junfeng Mao
- Yanan Chen
- Peng Sun
- Mengqi Shi
-
Affiliations: Department of Ophthalmology, Jingjiang People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu 214500, P.R. China, Department of Ophthalmology, The Jiamusi Center Hospital, Jiamusi, Heilongjiang 154002, P.R. China, Department of Ophthalmology, Taizhou Fourth People's Hospital, Taizhou, Jiangsu 225300, P.R. China - Published online on: July 2, 2025 https://doi.org/10.3892/ijmm.2025.5574
- Article Number: 133
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J and Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1309–1312. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA and Jin K: Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci. 27:304–307. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Du Y, Chen Q, Huang L, Wang S, Yin X, Zhou L, Ye Z, Ren X, Cai Y, Ding X, et al: VEGFR2 and VEGF-C suppresses the epithelial-mesenchymal transition via YAP in retinal pigment epithelial cells. Curr Mol Med. 18:273–286. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ and D'Amore PA: Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One. 3:e35542008. View Article : Google Scholar | |
|
Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA and Park JE: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 331:1480–1487. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Gunay BO and Esenulku CM: Retinal nerve fibre layer and ganglion cell layer thickness changes following intravitreal aflibercept for age-related macular degeneration. Cutan Ocul Toxicol. 41:91–97. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Arumuganathan N, Wiest MRJ, Toro MD, Hamann T, Fasler K and Zweifel SA: Acute and subacute macular and peripapillary angiographic changes in choroidal and retinal blood flow post-intravitreal injections. Sci Rep. 11:19381"2021. View Article : Google Scholar : PubMed/NCBI | |
|
Cheung CMG, Teo KYC, Tun SBB, Busoy JM, Veluchamy AB and Spaide RF: Differential reperfusion patterns in retinal vascular plexuses following increase in intraocular pressure an OCT angiography study. Sci Rep. 10:165052020. View Article : Google Scholar : PubMed/NCBI | |
|
Gómez-Mariscal M, Muñoz-Negrete FJ and Rebolleda Fernández G: Effects of intravitreal anti-VEGF therapy on glaucoma-like progression in susceptible eyes. J Glaucoma. 29:e54–e55. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Jonas JB, Budde WM and Panda-Jonas S: Ophthalmoscopic evaluation of the optic nerve head. Surv Ophthalmol. 43:293–320. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Alasil T, Wang K, Yu F, Field MG, Lee H, Baniasadi N, de Boer JF, Coleman AL and Chen TC: Correlation of retinal nerve fiber layer thickness and visual fields in glaucoma: A broken stick model. Am J Ophthalmol. 157:953–959. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sugimoto M, Nunome T, Sakamoto R, Kobayashi M and Kondo M: Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye. Graefes Arch Clin Exp Ophthalmol. 255:1543–1550. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Reinhard J, Renner M, Wiemann S, Shakoor DA, Stute G, Dick HB, Faissner A and Joachim SC: Ischemic injury leads to extracellular matrix alterations in retina and optic nerve. Sci Rep. 7:434702017. View Article : Google Scholar : PubMed/NCBI | |
|
Salminen A, Kauppinen A, Hyttinen JM, Toropainen E and Kaarniranta K: Endoplasmic reticulum stress in age-related macular degeneration: Trigger for neovascularization. Mol Med. 16:535–542. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Kruk J, Kubasik-Kladna K and Aboul-Enein HY: The role oxidative stress in the pathogenesis of eye diseases: Current status and a dual role of physical activity. Mini Rev Med Chem. 16:241–257. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Gao G, Li Y, Zhang D, Gee S, Crosson C and Ma J: Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 489:270–276. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Angayarkanni N, Selvi R, Pukhraj R, Biswas J, Bhavesh SJ and Tombran-Tink J: Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease. J Ocul Biol Dis Infor. 2:20–28. 2009. View Article : Google Scholar | |
|
Chen JF, Luo QH, Huang C, Liu WT, Zeng W, Gao Q, Chen P, Chen B and Chen ZL: Expression of VEGF and PEDF in early-stage retinopathy in diabetic Macaca mulatta. Nan Fang Yi Ke Da Xue Xue Bao. 37:1217–1221. 2017.In Chinese. PubMed/NCBI | |
|
Yamagishi S and Imaizumi T: Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des. 11:2279–2299. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yamagishi S, Matsui T, Nakamura K, Takeuchi M and Imaizumi T: Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis. Microvasc Res. 72:86–90. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, et al: Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem. 281:20213–20220. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Seddon JM, Gensler G, Milton RC, Klein ML and Rifai N: Association between C-reactive protein and age-related macular degeneration. JAMA. 291:704–710. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hachana S, Fontaine O, Sapieha P, Lesk M, Couture R and Vaucher E: The effects of anti-VEGF and kinin B (1) receptor blockade on retinal inflammation in laser-induced choroidal neovascularization. Br J Pharmacol. 177:1949–1966. 2020. View Article : Google Scholar : | |
|
Wang Y, Bian ZM, Yu WZ, Yan Z, Chen WC and Li XX: Induction of interleukin-8 gene expression and protein secretion by C-reactive protein in ARPE-19 cells. Exp Eye Res. 91:135–142. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lee MY, Park S, Song JY, Ra H, Baek JU and Baek J: Inflammatory cytokines and retinal nonperfusion area in quiescent proliferative diabetic retinopathy. Cytokine. 154:1557742022. View Article : Google Scholar : PubMed/NCBI | |
|
Sato T, Takeuchi M, Karasawa Y, Enoki T and Ito M: Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor. Sci Rep. 8:10982018. View Article : Google Scholar : PubMed/NCBI | |
|
Gong C, Qiao L, Feng R, Xu Q, Zhang Y, Fang Z, Shen J and Li S: IL-6-induced acetylation of E2F1 aggravates oxidative damage of retinal pigment epithelial cell line. Exp Eye Res. 200:1082192020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu ZY, Meng YA, Yan B and Luo J: Effect of anti-VEGF treatment on nonperfusion areas in ischemic retinopathy. Int J Ophthalmol. 14:1647–1652. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ and Dunaief JL: Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 49:358–363. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Arjamaa O, Nikinmaa M, Salminen A and Kaarniranta K: Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD). Ageing Res Rev. 8:349–358. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Feigl B: Age-related maculopathy-linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res. 28:63–86. 2009. View Article : Google Scholar | |
|
Roybal CN, Yang S, Sun CW, Hurtado D, Jagt DL, Townes TM and Abcouwer SF: Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem. 279:14844–14852. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Roybal CN, Hunsaker LA, Barbash O, Jagt DL and Abcouwer SF: The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism. J Biol Chem. 280:20331–20339. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Fernandes AF, Guo W, Zhang X, Gallagher M, Ivan M, Taylor A, Pereira P and Shang F: Proteasome-dependent regulation of signal transduction in retinal pigment epithelial cells. Exp Eye Res. 83:1472–1481. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Moenner M, Pluquet O, Bouchecareilh M and Chevet E: Integrated endoplasmic reticulum stress responses in cancer. Cancer Res. 67:10631–10634. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Feng Y, Wang C and Wang G: Inhibition of KCTD10 affects diabetic retinopathy progression by reducing VEGF and affecting angiogenesis. Genet Res (Camb). 2022:41123072022. View Article : Google Scholar : PubMed/NCBI | |
|
Roybal CN, Marmorstein LY, Jagt DL and Abcouwer SF: Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression. Invest Ophthalmol Vis Sci. 46:3973–3979. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Axer-Siegel R, Bourla D, Ehrlich R, Dotan G, Benjamini Y, Gavendo S, Weinberger D and Sela BA: Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am J Ophthalmol. 137:84–89. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ji C: Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. J Gastroenterol Hepatol. 23(Suppl 1): S16–S24. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chong EW, Kreis AJ, Wong TY, Simpson JA and Guymer RH: Alcohol consumption and the risk of age-related macular degeneration: A systematic review and meta-analysis. Am J Ophthalmol. 145:707–715. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kim LA and D'Amore PA: A brief history of anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol. 181:376–379. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wichrowska M, Goździewska E and Kocięcki J: The safety of Anti-VEGF treatment, in the context of the retinal nerve fibre layer, in patients with wet age-related macular degeneration: A review. Front Biosci (Landmark Ed). 28:2222023. View Article : Google Scholar : PubMed/NCBI | |
|
Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT and Chew EY: Age-related macular degeneration. Nat Rev Dis Primers. 7:312021. View Article : Google Scholar : PubMed/NCBI | |
|
Dugel PU, Koh A, Ogura Y, Jaffe GJ, Schmidt-Erfurth U, Brown DM, Gomes AV, Warburton J, Weichselberger A and Holz FG; HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 127:72–84. 2020. View Article : Google Scholar | |
|
Liberski S, Wichrowska M and Kocięcki J: Aflibercept versus faricimab in the treatment of neovascular age-related macular degeneration and diabetic macular edema: A review. Int J Mol Sci. 23:94242022. View Article : Google Scholar : PubMed/NCBI | |
|
Falavarjani KG and Nguyen QD: Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature. Eye (Lond). 27:787–794. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Tolentino M: Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol. 56:95–113. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N and Hillemeier J: Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond). 23:181–185. 2009. View Article : Google Scholar | |
|
Gismondi M, Salati C, Salvetat ML, Zeppieri M and Brusini P: Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma. 18:658–661. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Meyer CH, Michels S, Rodrigues EB, Hager A, Mennel S, Schmidt JC, Helb HM and Farah ME: Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections. Acta Ophthalmol. 89:70–75. 2011. View Article : Google Scholar | |
|
Ganssauge M, Wilhelm H, Bartz-Schmidt KU and Aisenbrey S: Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol. 247:1707–1710. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hosseini H and Razeghinejad MR: Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab. J Neuroophthalmol. 29:160–161. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Mansour AM, Bynoe LA, Welch JC, Pesavento R, Mahendradas P, Ziemssen F and Pai SA: Retinal vascular events after intravitreal bevacizumab. Acta Ophthalmol. 88:730–735. 2010. View Article : Google Scholar | |
|
Furino C, Boscia F, Cardascia N, Alessio G and Sborgia C: Hemorrhagic macular infarction after intravitreal bevacizumab for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 9:1–2. 2010. View Article : Google Scholar | |
|
Huang ZL, Lin KH, Lee YC, Sheu MM and Tsai RK: Acute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndrome. Ophthalmologica. 224:86–89. 2010. View Article : Google Scholar | |
|
Cakmak HB, Toklu Y, Yorgun MA and Simşek S: Isolated sixth nerve palsy after intravitreal bevacizumab injection. Strabismus. 18:18–20. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Damasceno NA, Yannuzzi NA, Maia M, Farah ME, Flynn HW Jr and Damasceno EF: Transient central retina artery occlusion in patients undergoing intravitreal anti vegf injections. Eur J Ophthalmol. 32:2819–2823. 2022. View Article : Google Scholar | |
|
Wichrowska M, Wichrowski P and Kocięcki J: Morphological and functional assessment of the optic nerve head and retinal ganglion cells in dry vs chronically treated wet age-related macular degeneration. Clin Ophthalmol. 16:2373–2384. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Lim HB, Sung JY, Ahn SI, Jo YJ and Kim JY: Retinal nerve fiber layer thickness in various retinal diseases. Optom Vis Sci. 95:247–255. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Dikmetas O, Gungor G, Kapucu Y, Kocabeyoglu S, Kadayıfcılar S, Eldem B, Karahan S and Cankaya AB: Short-term effect of macular edema on the peripapillary retinal nerve fiber layer in patients with wet age-related macular degeneration and diabetic macular edema: A comparative study. Photodiagnosis Photodyn Ther. 42:1036022023. View Article : Google Scholar : PubMed/NCBI | |
|
Martinez-de-la-Casa JM, Ruiz-Calvo A, Saenz-Frances F, Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J and Garcia-Feijoo J: Retinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumab. Invest Ophthalmol Vis Sci. 53:6214–6218. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Jun SY and Hwang DD: Short-term effect of intravitreal brolucizumab injections in patients with neovascular age-related macular degeneration on retinal nerve fiber layer thickness. Sci Rep. 13:66852023. View Article : Google Scholar : PubMed/NCBI | |
|
Valverde-Megías A, Ruiz-Calvo A, Murciano-Cespedosa A, Hernández-Ruiz S, Martínez-de-la-Casa JM and García-Feijoo J: Long-term effect of intravitreal ranibizumab therapy on retinal nerve fiber layer in eyes with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 257:1459–1466. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Parlak M, Oner FH and Saatci AO: The long-term effect of intravitreal ranibizumab on retinal nerve fiber layer thickness in exudative age-related macular degeneration. Int Ophthalmol. 35:473–480. 2015. View Article : Google Scholar | |
|
Chauhan BC, Danthurebandara VM, Sharpe GP, Demirel S, Girkin CA, Mardin CY, Scheuerle AF and Burgoyne CF: Bruch's membrane opening minimum rim width and retinal nerve fiber layer thickness in a normal white population: A multicenter study. Ophthalmology. 122:1786–1794. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Boltz A, Spöttl T, Huf W, Weingessel B and Vécsei-Marlovits VP: Effect of intravitreal injections due to neovascular age-related macular degeneration on retinal nerve fiber layer thickness and minimum rim width: A cross sectional study. BMC Ophthalmol. 24:1852024. View Article : Google Scholar : PubMed/NCBI | |
|
Law SK, Small KW and Caprioli J: Peripapillary retinal nerve fiber measurement with spectral-domain optical coherence tomography in age-related macular degeneration. Vision (Basel). 1:262017. View Article : Google Scholar : PubMed/NCBI | |
|
Ahn J, Jang K, Sohn J, Park JI and Hwang DD: Effect of intravitreal ranibizumab and aflibercept injections on retinal nerve fiber layer thickness. Sci Rep. 11:50102021. View Article : Google Scholar : PubMed/NCBI | |
|
Bitirgen G, Belviranli S, Malik RA, Kerimoglu H, Satirtav G and Zengin N: Assessment of corneal sensation, innervation and retinal nerve fiber layer in patients treated with multiple intravitreal ranibizumab injections. PLoS One. 12:e01702712017. View Article : Google Scholar : PubMed/NCBI | |
|
Demirel S, Batioğlu F, Özmert E and Erenler F: The effect of multiple injections of ranibizumab on retinal nerve fiber layer thickness in patients with age-related macular degeneration. Curr Eye Res. 40:87–92. 2015. View Article : Google Scholar | |
|
Zucchiatti I, Cicinelli MV, Parodi MB, Pierro L, Gagliardi M, Accardo A and Bandello F: Effect of intravitreal ranibizumab on ganglion cell complex and peripapillary retinal nerve fiber layer in neovascular age-related macular degeneration using spectral domain optical coherence tomography. Retina. 37:1314–1319. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
El-Ashry MF, Lascaratos G and Dhillon B: Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography. Clin Ophthalmol. 9:1269–1274. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sobacı G, Güngör R and Ozge G: Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure: A comparative clinical study. Int J Ophthalmol. 6:211–215. 2013. | |
|
Horsley MB, Mandava N, Maycotte MA and Kahook MY: Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 150558–561. (e551)2010. View Article : Google Scholar : PubMed/NCBI | |
|
Viggiano P, Buonamassa R, Grassi MO, Boscia G, Borrelli E, Landini L, Evangelista F, Malerba MG, Alessio G and Boscia F: Immediate effect of anti-VEGF injections on optic nerve head: Correlation between intraocular pressure and anatomical peripapillary changes. Eur J Ophthalmol. 34:1174–1182. 2024. View Article : Google Scholar | |
|
Entezari M, Ramezani A and Yaseri M: Changes in retinal nerve fiber layer thickness after two intravitreal bevacizumab injections for wet type age-related macular degeneration. J Ophthalmic Vis Res. 9:449–452. 2014. View Article : Google Scholar | |
|
Zivkovic M, Radosavljevic A, Zlatanovic M, Jaksic V, Davidovic S, Stamenkovic M, Todorovic I and Jaksic J: Influence of multiple Anti-VEGF injections on retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in patients with exudative age-related macular degeneration. Medicina (Kaunas). 59:1382023. View Article : Google Scholar : PubMed/NCBI | |
|
Klein BE, Klein R and Jensen SC: Open-angle glaucoma and older-onset diabetes. The beaver dam eye study Ophthalmology. 101:1173–1177. 1994. | |
|
Hoguet A, Chen PP, Junk AK, Mruthyunjaya P, Nouri-Mahdavi K, Radhakrishnan S, Takusagawa HL and Chen TC: The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma: A report by the american academy of ophthalmology. Ophthalmology. 126:611–622. 2019. View Article : Google Scholar | |
|
Khodabande A, Zarei M, Khojasteh H, Mohammadi M, Khameneh EA, Torkashvand A and Davoodabadi M: The effect of acute rises in intraocular pressure after intravitreal bevacizumab injection on the peripapillary retinal nerve fiber layer thickness and the role of anterior chamber paracentesis. J Curr Ophthalmol. 33:12–16. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Soheilian M, Karimi S, Montahae T, Nikkhah H and Mosavi SA: Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: A prospective study. Graefes Arch Clin Exp Ophthalmol. 255:1705–1712. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Levin AM, Chaya CJ, Kahook MY and Wirostko BM: Intraocular pressure elevation following intravitreal Anti-VEGF injections: Short- and long-term considerations. J Glaucoma. 30:1019–1026. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Mansoori T, Agraharam SG, Manwani S and Balakrishna N: Intraocular pressure changes after intravitreal bevacizumab or ranibizumab injection: A retrospective study. J Curr Ophthalmol. 33:6–11. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Karakahya RH: Anterior chamber paracentesis offers a less painful experience during intravitreal anti-vascular endothelial growth factor administration: An intraindividual study. Cureus. 13:e200512021. | |
|
Türksever C, Hoffmann L and Hatz K: Peripapillary and macular microvasculature in neovascular age-related macular degeneration in long-term and recently started anti-VEGF therapy versus healthy controls. Front. Med (Lausanne). 9:10800522023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Swaminathan SS, Yang J, Barikian A, Shi Y, Shen M, Jiang X, Feuer W, Gregori G and Rosenfeld PJ: Dose-Response relationship between intravitreal injections and retinal nerve fiber layer thinning in age-related macular degeneration. Ophthalmol Retina. 5:648–654. 2021. View Article : Google Scholar | |
|
Weinreb RN and Khaw PT: Primary open-angle glaucoma. Lancet. 363:1711–1720. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Sommer A, Miller NR, Pollack I, Maumenee AE and George T: The nerve fiber layer in the diagnosis of glaucoma. Arch Ophthalmol. 95:2149–2156. 1977. View Article : Google Scholar : PubMed/NCBI | |
|
Cho HK and Kee C: Rate of change in Bruch's membrane opening-minimum rim width and peripapillary RNFL in early normal tension glaucoma. J Clin Med. 9:23212020. View Article : Google Scholar : PubMed/NCBI | |
|
Choi HS, Joo CW, Park SP and Na KI: A decrease in Bruch's membrane opening-minimum rim area precedes decreased retinal nerve fiber layer thickness and visual field loss in glaucoma. J Glaucoma. 30:1033–1038. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
LoBue SA, Gindina S, Saba NJ, Chang T, Davis MJ and Fish S: Clinical features associated with acute elevated intraocular pressure after intravitreal anti-VEGF injections. Clin Ophthalmol. 17:1683–1690. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Gómez-Mariscal M, Puerto B, Muñoz-Negrete FJ, de Juan V and Rebolleda G: Acute and chronic optic nerve head biomechanics and intraocular pressure changes in patients receiving multiple intravitreal injections of anti-VEGF. Graefes Arch Clin Exp Ophthalmol. 257:2221–2231. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Enders P, Sitnilska V, Altay L, Schaub F, Muether PS and Fauser S: Retinal nerve fiber loss in anti-VEGF therapy for age-related macular degeneration can be decreased by anterior chamber paracentesis. Ophthalmologica. 237:111–118. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ranjbar M, Kurz M, Holzhey A, Rades D and Grisanti S: Changes in peripapillary nerve fiber layer thickness after adjuvant stereotactic radiotherapy in patients with neovascular age-related macular degeneration. Curr Eye Res. 42:1698–1706. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Moshfeghi DM, Kaiser PK and Gertner M: Stereotactic low-voltage x-ray irradiation for age-related macular degeneration. Br J Ophthalmol. 95:185–188. 2011. View Article : Google Scholar | |
|
Ranjbar M, Kurz M, Holzhey A, Melchert C, Rades D and Grisanti S: Stereotactic radiotherapy in neovascular age-related macular degeneration: Real-life efficacy and morphological evaluation of the outer retina-choroid complex. Medicine (Baltimore). 95:e57292016. View Article : Google Scholar : PubMed/NCBI | |
|
Jackson TL, Chakravarthy U, Slakter JS, Muldrew A, Shusterman EM, O'Shaughnessy D, Arnoldussen M, Gertner ME, Danielson L and Moshfeghi DM; INTREPID Study Group: Stereotactic radiotherapy for neovascular age-related macular degeneration: Year 2 results of the INTREPID study. Ophthalmology. 122:138–145. 2015. View Article : Google Scholar | |
|
Chan G, Balaratnasingam C, Xu J, Mammo Z, Han S, Mackenzie P, Merkur A, Kirker A, Albiani D, Sarunic MV and Yu DY: In vivo optical imaging of human retinal capillary networks using speckle variance optical coherence tomography with quantitative clinico-histological correlation. Microvasc Res. 100:32–39. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Mansoori T, Sivaswamy J, Gamalapati JS, Agraharam SG and Balakrishna N: Measurement of radial peripapillary capillary density in the normal human retina using optical coherence tomography angiography. J Glaucoma. 26:241–246. 2017. View Article : Google Scholar | |
|
Jo YH, Sung KR and Yun SC: The relationship between peripapillary vascular density and visual field sensitivity in primary open-angle and angle-closure glaucoma. Invest Ophthalmol Vis Sci. 59:5862–5867. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu G, Wang Y and Gao P: Distributions of radial peripapillary capillary density and correlations with retinal nerve fiber layer thickness in normal subjects. Med Sci Monit. 27:e9336012021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhuang X, Su Y, Li M, Zhang L, Mi L, Ji Y, Deng F, Xiao O, Zhang X, Zhou L, et al: A prospective observation of influence of anti-VEGF on optic disc vasculature in nAMD patients. Photodiagnosis Photodyn Ther. 45:1038632024. View Article : Google Scholar | |
|
Dugel PU, Singh RP, Koh A, Ogura Y, Weissgerber G, Gedif K, Jaffe GJ, Tadayoni R, Schmidt-Erfurth U and Holz FG: HAWK and HARRIER: Ninety-Six-week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 128:89–99. 2021. View Article : Google Scholar | |
|
Holz FG, Dugel PU, Weissgerber G, Hamilton R, Silva R, Bandello F, Larsen M, Weichselberger A, Wenzel A, Schmidt A, et al: Single-Chain antibody fragment VEGF inhibitor RTH258 for neovascular age-related macular degeneration: A randomized controlled study. Ophthalmology. 123:1080–1089. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Dugel PU, Jaffe GJ, Sallstig P, Warburton J, Weichselberger A, Wieland M and Singerman L: Brolucizumab versus aflibercept in participants with neovascular age-related macular degeneration: A randomized trial. Ophthalmology. 124:1296–1304. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lee K, Bae HW, Lee SY, Seong GJ and Kim CY: Hierarchical cluster analysis of peripapillary retinal nerve fiber layer damage and macular ganglion cell loss in open angle glaucoma. Korean J Ophthalmol. 34:56–66. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hollands H, Johnson D, Hollands S, Simel DL, Jinapriya D and Sharma S: Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA. 309:2035–2042. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rud'ko AS, Budzinskaya MV, Andreeva IV, Karpilova MA and Smirnova TV: Effect of intravitreal injections of ranibizumab and aflibercept on the retinal nerve fiber layer in patients with concomitant neovascular age-related macular degeneration and glaucoma. Vestn Oftalmol. 135:177–183. 2019.In Russian. View Article : Google Scholar | |
|
Kopić A, Biuk D, Barać J, Vinković M, Benašić T and Kopić V: Retinal nerve fiber layer thickness in glaucoma patients treated with multiple intravitreal anti-Vegf (Bevacizumab) injections. Acta Clin Croat. 56:406–414. 2017. | |
|
Hwang DJ, Lee EJ, Lee SY, Park KH and Woo SJ: Effect of diabetic macular edema on peripapillary retinal nerve fiber layer thickness profiles. Invest Ophthalmol Vis Sci. 55:4213–4219. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yau GL, Campbell RJ, Li C and Sharma S: Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degeneration. Can J Ophthalmol. 50:345–349. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yang HS, Woo JE, Kim MH, Kim DY and Yoon YH: Co-Evaluation of peripapillary RNFL thickness and retinal thickness in patients with diabetic macular edema: RNFL misinterpretation and its adjustment. PLoS One. 12:e01703412017. View Article : Google Scholar : PubMed/NCBI | |
|
Fong DS, Ferris FL III, Davis MD and Chew EY: Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early treatment diabetic retinopathy study research group. Am J Ophthalmol. 127:137–141. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Viggiano P, Grassi MO, Bisceglia G, Boscia G, Borrelli E, Malerba MG, Fracchiolla A, Alessio G and Boscia F: Short-term peripapillary structural and vascular changes following anti-VEGF vs. Dexamethasone intravitreal therapy in patients with DME. Eur J Ophthalmol. 33:2236–2242. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 103:1796–1806. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Scott IU, Danis RP, Bressler SB, Bressler NM, Browning DJ and Qin H; Diabetic Retinopathy Clinical Research Network: Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema. Retina. 29:613–617. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Eren S, Ozturk T, Yaman A, Oner H and A OS: Retinal nerve fiber layer alterations after photocoagulation: A prospective spectral-domain OCT study. Open Ophthalmol J. 8:82–86. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Roohipour R, Sharifian E, Moghimi S, Fard MA, Ghassemi F, Zarei M, Davoodi S, Bazvand F and Modjtahedi BS: The effect of panretinal photocoagulation (PRP) versus intravitreal bevacizumab (IVB) plus PRP on peripapillary retinal nerve fiber layer (RNFL) thickness analyzed by optical coherence tomography in patients with proliferative diabetic retinopathy. J Ophthalmic Vis Res. 14:157–163. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Jampol LM, Odia I, Glassman AR, Baker CW, Bhorade AM, Han DP, Jaffe GJ, Melia M, Bressler NM and Tanna AP; Diabetic Retinopathy Clinical Research Network: Panretinal photocoagulation versus ranibizumab for proliferative diabetic retinopathy: Comparison of peripapillary retinal nerve fiber layer thickness in a randomized clinical trial. Retina. 39:69–78. 2019. View Article : Google Scholar : | |
|
Shin YI, Lim HB, Koo H, Lee WH and Kim JY: Longitudinal changes in the peripapillary retinal nerve fiber layer thickness in the fellow eyes of unilateral retinal vein occlusion. Sci Rep. 10:77082020. View Article : Google Scholar : PubMed/NCBI | |
|
Klein R, Klein BE, Moss SE and Meuer SM: The epidemiology of retinal vein occlusion: The beaver dam eye study. Trans Am Ophthalmol Soc. 98:133–141. 2000. | |
|
Hahn P and Fekrat S: Best practices for treatment of retinal vein occlusion. Curr Opin Ophthalmol. 23:175–181. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Pulido JS, Flaxel CJ, Adelman RA, Hyman L, Folk JC and Olsen TW: Retinal vein occlusions preferred practice pattern (®) guidelines. Ophthalmology. 123:P182–P208. 2016. View Article : Google Scholar | |
|
Zhang M, Liu Y, Song M, Yu Y, Ruan S, Zheng K, Wang F and Sun X: Intravitreal dexamethasone implant has better retinal perfusion than anti-vascular endothelial growth factor treatment for macular edema secondary to retinal vein occlusion: A five-year real-world study. Ophthalmic Res. 66:247–258. 2023. View Article : Google Scholar | |
|
Ahn J and Hwang DD: Peripapillary retinal nerve fiber layer thickness in patients with unilateral retinal vein occlusion. Sci Rep. 11:181152021. View Article : Google Scholar : PubMed/NCBI | |
|
Goda I, Saliem EA, Mostafa SM, Amin AM, Omran MY, Eltantawy B, Soliman HB, Abu El-Wafa EG, Abdelgbar AA, Osman HO, et al: Longitudinal changes in peri-papillary retinal nerve fiber layer thickness in patients with unilateral branch retinal vein occlusion. Med Hypothesis Discov Innov Ophthalmol. 12:62–69. 2023. View Article : Google Scholar | |
|
Moleiro AF, Godinho G, Madeira C, Pereira AF, Brandão E, Falcão-Reis F, Beato JN and Penas S: Peripapillary and subfoveal choroidal thickness in retinal vein occlusions. Clin Ophthalmol. 16:3775–3783. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Munk MR, Ceklic L, Stillenmunkes R, Chaudhary V, Waheed N, Chhablani J, de Smet MD and Tillmann A: Integrated assessment of OCT, multimodal imaging, and cytokine markers for predicting treatment responses in retinal vein occlusion associated macular edema: A comparative review of Anti-VEGF and steroid therapies. Diagnostics (Basel). 14:19832024. View Article : Google Scholar : PubMed/NCBI | |
|
Shin YI, Nam KY, Lee SE, Lim HB, Lee MW, Jo YJ and Kim JY: Changes in peripapillary microvasculature and retinal thickness in the fellow eyes of patients with unilateral retinal vein occlusion: An OCTA study. Invest Ophthalmol Vis Sci. 60:823–829. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu Y, Sun T, Xu F, Gao P, Tang G and Peng Q: Correlation of vascular change and cognitive impairment in age-related macular degeneration patients. Am J Transl Res. 13:336–348. 2021.PubMed/NCBI | |
|
Fontaine O, Olivier S, Descovich D, Cordahi G, Vaucher E and Lesk MR: The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration. Invest Ophthalmol Vis Sci. 52:7400–7405. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kato N, Haruta M, Furushima K, Arai R, Matsuo Y and Yoshida S: Decrease in ocular blood flow thirty minutes after intravitreal injections of brolucizumab and aflibercept for neovascular age-related macular degeneration. Clin Ophthalmol. 17:1187–1192. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Mursch-Edlmayr AS, Luft N, Podkowinski D, Ring M, Schmetterer L and Bolz M: Effects of three intravitreal injections of aflibercept on the ocular circulation in eyes with age-related maculopathy. Br J Ophthalmol. 104:53–57. 2020. View Article : Google Scholar | |
|
Mursch-Edlmayr AS, Luft N, Podkowinski D, Ring M, Schmetterer L and Bolz M: Short-term effect on the ocular circulation induced by unilateral intravitreal injection of aflibercept in age-related maculopathy. Acta Ophthalmol. 97:e927–e932. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ding X, Lu L, Yang J, Chen Y and Ma J: The peripapillary retinal capillary density is highly correlated with its nerve fibre layer in normal population. Clin Hemorheol Microcirc. 74:231–239. 2020. View Article : Google Scholar | |
|
Jager RD, Mieler WF and Miller JW: Age-related macular degeneration. N Engl J Med. 358:2606–2617. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sakurada Y, Nakamura Y, Yoneyama S, Mabuchi F, Gotoh T, Tateno Y, Sugiyama A, Kubota T and Iijima H: Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Ophthalmic Res. 53:2–7. 2015. View Article : Google Scholar | |
|
Obeng-Aboagye E, Frimpong A, Amponsah JA, Danso SE, Owusu EDA and Ofori MF: Inflammatory cytokines as potential biomarkers for early diagnosis of severe malaria in children in Ghana. Malar J. 22:2202023. View Article : Google Scholar : PubMed/NCBI | |
|
Pessoa B, Melo-Beirão J, Meireles A and Menéres P: Challenging clinical cases-a walk through supplemental therapy with intravitreal ranibizumab therapy following treatment of diabetic macular edema with the 0.19 mg fluocinolone acetonide implant (ILUVIEN®. Int Med Case Rep J. 13:437–448. 2020. | |
|
Barash A, Chui TYP, Garcia P and Rosen RB: Acute macular and peripapillary angiographic changes with intravitreal injections. Retina. 40:648–656. 2020. View Article : Google Scholar | |
|
Baek SU, Park IW and Suh W: Long-term intraocular pressure changes after intravitreal injection of bevacizumab. Cutan Ocul Toxicol. 35:310–314. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng L, Liu X, Chen S and Ma J: Quantitative analysis of peripapillary capillary volume using dense B-scan OCT angiography in normal and diabetic retina. Eye Vis (Lond). 11:342024. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Busoy JM, Zaman BAA, Tan QSW, Tan GSW, Barathi VA, Cheung N, Wei JJ, Hunziker W, Hong W, et al: A novel model of persistent retinal neovascularization for the development of sustained anti-VEGF therapies. Exp Eye Res. 174:98–106. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, et al: Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: A randomized clinical trial. JAMA. 314:2137–2146. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Reddy SV and Husain D: Panretinal photocoagulation: A review of complications. Semin Ophthalmol. 33:83–88. 2018. View Article : Google Scholar | |
|
Soman M, Ganekal S, Nair U and Nair K: Effect of panretinal photocoagulation on macular morphology and thickness in eyes with proliferative diabetic retinopathy without clinically significant macular edema. Clin Ophthalmol. 6:2013–2017. 2012.PubMed/NCBI | |
|
Helmy AMR, Rashad MA, Gharieb HM, Gomaa WA and Zaki RGE: Optic nerve head perfusion changes in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab or photocoagulation: A randomized controlled trial. Med Hypothesis Discov Innov Ophthalmol. 11:144–150. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Fan L, Zhu Y, Sun X, Yu J and Yan H: Patients with unilateral retinal vein occlusion show reduced radial peripapillary capillary density in their fellow eyes. BMC Ophthalmol. 21:4482021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Q, Chan SY, Yan Y, Yang J, Zhou W, Jonas JB and Wei WB: Optical coherence tomography angiography in retinal vein occlusions. Graefes Arch Clin Exp Ophthalmol. 256:1615–1622. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Finkelstein D: Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology. 93:975–977. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Hayashi K and Hayashi H: Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 139:972–982. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kumagai K, Furukawa M, Ogino N, Uemura A and Larson E: Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina. 27:49–54. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ehlers JP, Kim SJ, Yeh S, Thorne JE, Mruthyunjaya P, Schoenberger SD and Bakri SJ: Therapies for macular edema associated with branch retinal vein occlusion: A report by the american academy of ophthalmology. Ophthalmology. 124:1412–1423. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S: Effect of anti-VEGF therapy on optic disc microcirculation in patients with macular edema secondary to branch retinal vein occlusion based on OCTA. MA thesis. Gannan Medical College; Gannan: pp. 16–21. 2022, In Chinese. | |
|
Sun J: The changes of radial peripapillary capillary density before and after anti-VEGF treatments in patients with branch retinal vein occlusion complicated with macular edema were evaluated by OCTA. MA thesis. Chengde Medical College; Chengde: pp. 17–22. 2022, In Chinese. | |
|
Tan C: Detection and correlation analysis of microvessel density and nerve fiber layer thickness in optic disc before and after anti-vascular endothelial growth factor treatment in patients with retinal vein occlusion. MA thesis. Bengbu Medical College; Bengbu: pp. 25–30. 2021, In Chinese. | |
|
Nicolai M, Franceschi A, Turris S, Rosati A, Pirani V and Mariotti C: Papillary vessel density changes after intravitreal Anti-VEGF injections in hypertensive patients with central retinal vein occlusion: An angio-OCT study. J Clin Med. 8:16362019. View Article : Google Scholar : PubMed/NCBI | |
|
Asano T, Kunikata H, Yasuda M, Nishiguchi KM, Abe T and Nakazawa T: Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab. Int Ophthalmol. 41:151–162. 2021. View Article : Google Scholar | |
|
Nagasato D, Mitamura Y, Semba K, Akaiwa K, Nagasawa T, Yoshizumi Y, Tabuchi H and Kiuchi Y: Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: Prospective, interventional case series. BMC Ophthalmol. 16:362016. View Article : Google Scholar : PubMed/NCBI | |
|
Fukami M, Iwase T, Yamamoto K, Kaneko H, Yasuda S and Terasaki H: Changes in retinal microcirculation after intravitreal ranibizumab injection in eyes with macular edema secondary to branch retinal vein occlusion. Invest Ophthalmol Vis Sci. 58:1246–1255. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Toto L, Evangelista F, Viggiano P, Erroi E, D'Onofrio G, Libertini D, Porreca A, D'Aloisio R, Mariacristina P, Di Antonio L, et al: Changes in ocular blood flow after ranibizumab intravitreal injection for diabetic macular edema measured using laser speckle flowgraphy. Biomed Res Int. 2020:94962422020. View Article : Google Scholar : PubMed/NCBI | |
|
Mizukami T, Mizumoto S, Ishibashi T, Ueno S, Toyonishi T, Tachibana K, Mishima S and Shimomura Y: Changes in ocular blood flow after intravitreal injection for diabetic macular edema between aflibercept and faricimab. Clin Ophthalmol. 18:2407–2416. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Consigli A, Papanastasiou A, Roquelaure D, Wuarin R, Roy S, Thumann G and Chronopoulos A: Changes in retinal vascular caliber after intravitreal aflibercept treatment for diabetic macular oedema. Klin Monbl Augenheilkd. 236:1318–1324. 2019.In German. | |
|
Förstermann U and Sessa WC: Nitric oxide synthases: Regulation and function. Eur Heart J. 33:829–837. 2012. View Article : Google Scholar : | |
|
Thulliez M, Angoulvant D, Lez ML, Jonville-Bera AP, Pisella PJ, Gueyffier F and Bejan-Angoulvant T: Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: Systematic review and meta-analysis. JAMA Ophthalmol. 132:1317–1326. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fung AE, Rosenfeld PJ and Reichel E: The international intravitreal bevacizumab safety survey: Using the internet to assess drug safety worldwide. Br J Ophthalmol. 90:1344–1349. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kitchens JW, Do DV, Boyer DS, Thompson D, Gibson A, Saroj N, Vitti R, Berliner AJ and Kaiser PK: Comprehensive review of ocular and systemic safety events with intravitreal aflibercept injection in randomized controlled trials. Ophthalmology. 123:1511–1520. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Buyukavsar C, Sonmez M, Sagdic SK and Unal MH: Relationship between ganglion cell complex thickness and vision in age-related macular degeneration treated with aflibercept. Eur J Ophthalmol. 33:1672–1682. 2023. View Article : Google Scholar | |
|
Dziedziak J, Zaleska-Żmijewska A, Szaflik JP and Cudnoch-Jędrzejewska A: Impact of arterial hypertension on the eye: A review of the pathogenesis, diagnostic methods, and treatment of hypertensive retinopathy. Med Sci Monit. 28:e9351352022. View Article : Google Scholar : PubMed/NCBI | |
|
Kiyat P and Karti O: Comparison of choroidal vascularity index, retinal, and optic nerve changes in diabetes mellitus patients without diabetic retinopathy. Beyoglu Eye J. 9:228–234. 2024. View Article : Google Scholar | |
|
Swaminathan SS, Jammal AA, Berchuck SI and Medeiros FA: Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma. Am J Ophthalmol. 229:100–107. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Kim MJ, Woo SJ, Park KH and Kim TW: Retinal nerve fiber layer thickness is decreased in the fellow eyes of patients with unilateral retinal vein occlusion. Ophthalmology. 118:706–710. 2011. View Article : Google Scholar | |
|
Qin HF, Shi FJ, Zhang CY, Luo DW, Qin SY, Wu J, Xie H, Zhang JT, Qiu QH, Liu K, et al: Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion. Int J Ophthalmol. 15:1296–1304. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Imazeki M, Noma H, Yasuda K, Motohashi R, Goto H and Shimura M: Anti-VEGF therapy reduces inflammation in diabetic macular edema. Ophthalmic Res. 64:43–49. 2021. View Article : Google Scholar | |
|
Nakao S, Arima M, Ishikawa K, Kohno R, Kawahara S, Miyazaki M, Yoshida S, Enaida H, Hafezi-Moghadam A, Kono T and Ishibashi T: Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Invest Ophthalmol Vis Sci. 53:4323–4328. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP and Shima DT: Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol. 171:53–67. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Zhang Z, Jiang L, He S, Long X and Zheng X: Combination therapy with N-Acetylserotonin and aflibercept activated the Akt/Nrf2 pathway to inhibit apoptosis and oxidative stress in rats with retinal ischemia-reperfusion injury. Curr Eye Res. 4:280–287. 2024. View Article : Google Scholar | |
|
Rani EA, Janani R, Chonche MJ and Vallikannan B: Lactucaxanthin regulates the cascade of retinal oxidative stress, endoplasmic reticulum stress and inflammatory signaling in diabetic rats. Ocul Immunol Inflamm. 31:320–328. 2023. View Article : Google Scholar |
